Login

Leon Benjamin, President and CEO of the Glimpse Group, was warmly welcomed at Nasdaq's listing ceremony. 00:10:00

Share On Facebook Share On Twitter

Lyron L Bentovim is Pres/CEO/Co-Founder at Glimpse Group Inc

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
NioBay Metals: Advancing the James Bay Niobium Project and Raising Investor Awareness
00:00:00
Görgen Nilsson, CEO, ScandiDos
00:10:00
Technology Minerals: Pioneering EV Battery Metals Recycling and Mining on the London Stock Exchange
00:10:00
Proactive Financial Planning for a Secure Future
00:10:00
Exploring Company Achievements: Insights on Water Tank Success and Future Prospects|LALIT DAMODAR MEHTA,Managing Director,Samrat Pharmachem Ltd.
00:10:00
Thomas Wagner discusses PG&E Corp.'s restructuring and the pandemic's impact on credit markets with Bloomberg's Erik Schatzker on "Bloomberg Daybreak: Americas."
00:10:00
Secure Your Future with Expert Financial Guidance | Trent Porter, Financial Advisor & CEO of priority financial partners
00:10:00
Navigating Client Relationships in Asset Management
00:10:00
Don't be an entrepreneur|Ahmed El Alfi,Founder,Flat6Labs
00:10:00
David Herro, Harris Associates CIO of international equities and portfolio manager, joins 'Squawk on the Street' to discuss the European market outlook.
00:10:00
The Seventh Most Common Retirement Question: Should I Convert IRA Assets into a Roth IRA? | Dana Anspach, CEO , Sensible Money, LLC.
00:00:00
Diving Deeper Into the Background CEO -Dane C. Andreeff President and Chief Executive Officer , Helius Medical Technologies Inc

© 2017 - Neuhu+